(USD) | Jan 2024 | Q/Q |
---|---|---|
Revenue | -474.8MM | -291% |
Gross Profit | -293.8MM | -285% |
Cost Of Revenue | -181MM | -299% |
Operating Income | 38.9MM | +26% |
Operating Expenses | -253.9MM | -299% |
Net Income | -3MM | -120% |
R&D | 55.2MM | -1% |
G&A | 25.3MM | -4% |
Marketing | 20.6MM | +5% |
Amortization | 35.5MM | -1% |
Interest Expense | 13.6MM | +1% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
HealthEquity's (HQY) sustained strength in HSAs raises optimism about the stock.
It’s the most basic question investors face: What stocks to buy? The markets are tossing up a huge volume of data from millions upon millions of daily transactions, involving thousands of traders, dealers, and brokers, and thousands of public stocks. The data makes an imposing edifice – and is tailor made for data sorting tools like the Smart Score. The Smart Score is an AI-powered natural language algorithm, sophisticated enough to scan, collect, collate, and analyze all those reams of data – a
New study indicates that benefits professionals are in an ‘early adopter’ stage with AIDRAPER, Utah, April 04, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (Nasdaq: HQY) ("HealthEquity") released the findings of a new survey on Artificial Intelligence (AI) in benefits administration. The survey provides a benchmark on senior benefit leaders’ attitude toward AI-enabled benefits tools. A majority (73%) of the more than 800 respondents surveyed believe that AI will have a positive influence on benef
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
On March 26, 2024, Director Evelyn Dilsaver executed a significant stock sale of HealthEquity Inc (NASDAQ:HQY).
In this article, we will take a detailed look at Insiders Are Dumping These 10 Healthcare Stocks. For a quick overview of such stocks, read our article Insiders Are Dumping These 5 Healthcare Stocks. Healthcare-focused investors were nervous when 2024 started, since election years usually do not bode well for the healthcare industry amid policy-related uncertainties. But healthcare stocks […]
HealthEquity ( NASDAQ:HQY ) Full Year 2024 Results Key Financial Results Revenue: US$999.6m (up 16% from FY 2023). Net...
Q4 2024 Healthequity Inc Earnings Call
HealthEquity (HQY) witnesses solid growth in HSAs, besides recording robust performances in the majority of its segments, in the fourth quarter of fiscal 2024.